Tech Company Financing Transactions

Optherion Funding Round

Optherion closed a $37 million Series A venture capital round on 10/9/2007. Investors included Biogen Idec, Domain Associates and Johnson & Johnson Development Corporation.

Transaction Overview

Company Information

Company Status

Acquired or Merged

Industry

Biopharmaceutical

Mailing Address

555 Long Wharf Drive 11th Floor
New Haven, CT 06511
USA

Phone

(203) 781-0072

Website

www.optherion.com

Email Address

[email protected]

Overview

Optherion, Inc. is an early-stage biotechnology company that is developing diagnostic and disease-modifying products for the management and treatment of dry and wet Age-related Macular Degeneration (AMD) and other chronic diseases involving the alternative complement system.Optherion's intellectual properties are based on recent scientific discoveries linking certain genes to AMD.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Colin Foster

        

Browse more venture capital transactions:

Prev: 10/9/2007: AngioScore venture capital transaction
Next: 10/10/2007: Outside.in venture capital transaction

Share this article

News on VC Transactions

We do our best to record funding rounds that are announced publicly. VC investment data records on this site are derived from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary